Among other biological markers, interleukin 18 (IL-18) appears as a reasonable candidate for a better understanding of adult-onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA) pathophysiology, evaluation of disease activity, and therapeutic approaches. Here, IL18 is linked to systemic-onset juvenile idiopathic arthritis.